SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-032236
Filing Date
2021-12-22
Accepted
2021-12-22 08:30:12
Documents
14
Period of Report
2021-12-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35526
2 ex99-1.htm EX-99.1 16840
3 ex99-1_001.jpg GRAPHIC 6689
  Complete submission text file 0001493152-21-032236.txt   237604

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cocp-20211222.xsd EX-101.SCH 3046
5 XBRL LABEL FILE cocp-20211222_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cocp-20211222_pre.xml EX-101.PRE 22373
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3470
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 211511054
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences